MedPath
TGA Approval

RAPIFEN alfentanil 5mg/10mL (as hydrochloride) injection, ampoule (50508)

50508

RAPIFEN alfentanil 5mg/10mL (as hydrochloride) injection, ampoule

Piramal Critical Care Pty Ltd

October 14, 1994

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-CMI-01400-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-PI-01399-1

Active Ingredients

alfentanil hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RAPIFEN alfentanil 5mg/10mL (as hydrochloride) injection, ampoule (50508) - TGA 批准文号 | MedPath